Post by Lonza

Lonza is heading to World ADC Summit South Korea. Our bioconjugates experts will be in Seoul to connect, exchange insights, and explore how we can support your ADC development journey. Join the presentation by Marcel Scheepstra, Director, Organic Chemistry, Advanced Synthesis R&D on Thursday, 11 June at 08:30 AM: “Lonza’s End-to-End Offering for Best-in-Class Targeted Therapies Based on GlycoConnect® & HydraSpace® Technologies.” We look forward to discussing your challenges and demonstrating how our integrated capabilities can help move your program forward. 👉 Connect with us via the partnering app to schedule a meeting. #Lonza #ADC #Bioconjugates #WorldADC #TargetedTherapies #ConnectToAdvance